Jefferies Group LLC Kamada LTD Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.43 - $6.81 $144,562 - $181,302	-26,623 Closed	0 $0
Q4 2021 Sep 21, 2023	SELL	$5.21 - $6.82 $532,118 - $696,553	-102,134 Reduced 79.32%	26,623 $175,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $6.82 $532,118 - $696,553	-102,134 Reduced 79.32%	26,623 $175,000
Q3 2021 Sep 21, 2023	BUY	$5.25 - $5.87 $206,167 - $230,514	39,270 Added 43.88%	128,757 $682,000
Q3 2021 Nov 15, 2021	BUY	$5.25 - $5.87 $206,167 - $230,514	39,270 Added 43.88%	128,757 $682,000
Q2 2021 Sep 21, 2023	BUY	$5.67 - $6.33 $507,391 - $566,452	89,487 New	89,487 $520,000
Q2 2021 Aug 16, 2021	BUY	$5.67 - $6.33 $507,391 - $566,452	89,487 New	89,487 $521,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.